BACKGROUND: Cancer survivors may experience long-term and late effects from treatment that adversely affect health and limit functioning. Few studies examine lost productivity and disease burden in cancer survivors compared with individuals who have other chronic conditions or by cancer type. METHODS: We identified 4960 cancer survivors and 64,431 other individuals from the 2008-2010 Medical Expenditure Panel Survey and compared multiple measures of disease burden, including health status and lost productivity, between conditions and by cancer site for cancer survivors. All analyses controlled for the effects of age, sex, race/ethnicity, and number of comorbid conditions. RESULTS: Overall, in adjusted analyses in multiple models, cancer survivors with another chronic disease (heart disease or diabetes) experienced higher levels of burden compared with individuals with a history of cancer only, chronic disease only, and neither cancer, heart disease, nor diabetes across multiple measures (P < .05). Among cancer survivors, individuals with short survival cancers and multiple cancers consistently had the highest levels of burden across multiple measures (P < .0001). CONCLUSIONS: Cancer survivors who have another chronic disease experience more limitations and higher levels of burden across multiple measures. Limitations are particularly severe in cancer survivors with short survival cancer and multiple cancers.
BACKGROUND:Cancer survivors may experience long-term and late effects from treatment that adversely affect health and limit functioning. Few studies examine lost productivity and disease burden in cancer survivors compared with individuals who have other chronic conditions or by cancer type. METHODS: We identified 4960 cancer survivors and 64,431 other individuals from the 2008-2010 Medical Expenditure Panel Survey and compared multiple measures of disease burden, including health status and lost productivity, between conditions and by cancersite for cancer survivors. All analyses controlled for the effects of age, sex, race/ethnicity, and number of comorbid conditions. RESULTS: Overall, in adjusted analyses in multiple models, cancer survivors with another chronic disease (heart disease or diabetes) experienced higher levels of burden compared with individuals with a history of cancer only, chronic disease only, and neither cancer, heart disease, nor diabetes across multiple measures (P < .05). Among cancer survivors, individuals with short survival cancers and multiple cancers consistently had the highest levels of burden across multiple measures (P < .0001). CONCLUSIONS:Cancer survivors who have another chronic disease experience more limitations and higher levels of burden across multiple measures. Limitations are particularly severe in cancer survivors with short survival cancer and multiple cancers.
Authors: Nancy L Keating; Marie Nørredam; Mary Beth Landrum; Haiden A Huskamp; Ellen Meara Journal: J Am Geriatr Soc Date: 2005-12 Impact factor: 5.562
Authors: K Robin Yabroff; William W Davis; Elizabeth B Lamont; Angela Fahey; Marie Topor; Martin L Brown; Joan L Warren Journal: J Natl Cancer Inst Date: 2007-01-03 Impact factor: 13.506
Authors: K Robin Yabroff; Emily Dowling; Juan Rodriguez; Donatus U Ekwueme; Helen Meissner; Anita Soni; Catherine Lerro; Gordon Willis; Laura P Forsythe; Laurel Borowski; Katherine S Virgo Journal: J Cancer Surviv Date: 2012-07-19 Impact factor: 4.442
Authors: Sun Hee Rim; Gery P Guy; K Robin Yabroff; Kathleen A McGraw; Donatus U Ekwueme Journal: Expert Rev Pharmacoecon Outcomes Res Date: 2016-10-06 Impact factor: 2.217
Authors: Zhiyuan Zheng; Xuesong Han; Gery P Guy; Amy J Davidoff; Chunyu Li; Matthew P Banegas; Donatus U Ekwueme; K Robin Yabroff; Ahmedin Jemal Journal: Cancer Date: 2017-02-20 Impact factor: 6.860
Authors: Sapna Kaul; Jaqueline C Avila; Daniel Jupiter; Ana M Rodriguez; Anne C Kirchhoff; Yong-Fang Kuo Journal: J Cancer Res Clin Oncol Date: 2017-08-22 Impact factor: 4.553
Authors: Robin L Whitney; Janice F Bell; Sarah C Reed; Rebecca Lash; Richard J Bold; Katherine K Kim; Andra Davis; David Copenhaver; Jill G Joseph Journal: J Cancer Surviv Date: 2015-07-19 Impact factor: 4.442
Authors: I-Chan Huang; Melissa M Hudson; Leslie L Robison; Kevin R Krull Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-03-23 Impact factor: 4.254
Authors: Gery P Guy; K Robin Yabroff; Donatus U Ekwueme; Sun Hee Rim; Rui Li; Lisa C Richardson Journal: J Clin Oncol Date: 2017-05-04 Impact factor: 44.544